Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Rituximab Hyaluronidase |
Trade Name | |
Synonyms | Rituxan Hycela|Rituximab and Hyaluronidase Human|Rituximab/Hyaluronidase |
Drug Descriptions |
Rituximab Hyaluronidase consists of a preparation of the CD20 antibody Rituxan (rituximab) combined with hyaluronidase, which upon delivery leads to break down of tissue hyaluronan by the hyaluronidase component, resulting in increased rituximab absorption and potentially resulting in enhanced complement-dependent and antibody-dependent cytotoxicity against CD20-positive tumor cells (NCI Drug Dictionary). |
DrugClasses | CD20 Antibody 24 |
CAS Registry Number | NA |
NCIT ID | C136821 |